Aptose Biosciences Inc.

Home
About
Product Pipeline
Clinical Trials
News
Investors
Join Us
Contact

IR Calendar

Investors

Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR
Governance

News & Events
Overview
Press Releases
IR Calendar
Email Alerts

Key Opinion Leader Breakfast: Novel Treatment for AML and B-cell Cancers

Dec 12, 2018 • 8:00 am EDT

Email Alerts
Contacts
RSS News Feed

© 2024 Aptose Biosciences Inc. All Rights Reserved.

Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences